1. His22 of TLXI plays a critical role in the inhibition of glycoside hydrolase family 11 xylanases
- Author
-
Kurt Gebruers, Ellen Fierens, Johnny Beaugrand, Anja Rabijns, Sigrid Rombouts, Marc De Maeyer, Guido Volckaert, Elien Vandermarliere, Steven Van Campenhout, Arnout Voet, Jan A. Delcour, and Christophe M. Courtin
- Subjects
Models, Molecular ,Glycoside Hydrolases ,Mutant ,medicine.disease_cause ,Pichia pastoris ,Protein–protein interaction ,Mutant protein ,Drug Discovery ,Glycoside hydrolase family 11 ,medicine ,Histidine ,Glycoside hydrolase ,Cloning, Molecular ,Site-directed mutagenesis ,Triticum ,Plant Proteins ,Pharmacology ,Mutation ,Endo-1,4-beta Xylanases ,biology ,food and beverages ,General Medicine ,biology.organism_classification ,Biochemistry ,Mutagenesis, Site-Directed ,Protein Binding - Abstract
Recently, a novel wheat thaumatin-like protein, TLXI, which inhibits microbial glycoside hydrolase family (GH) 11 xylanases has been identified. It is the first xylanase inhibitor that exerts its inhibition in a non-competitive way. In the present study we gained insight into the interaction between TLXI and xylanases via combined molecular modeling and mutagenic approaches. More specifically, site-specific mutation of His22, situated on a loop which distinguishes TLXI from other, non-inhibiting, thaumatin-like proteins, and subsequent expression of the mutant in Pichia pastoris resulted in a protein lacking inhibition capacity. The mutant protein was unable to form a complex with GH11 xylanases. Based on these findings, the interaction of TLXI with GH11 xylanases is discussed. ispartof: Journal of enzyme inhibition and medicinal chemistry vol:24 issue:1 pages:38-46 ispartof: location:England status: published
- Published
- 2009